Back to Journals » Medical Devices: Evidence and Research » Volume 7

Day-to-day repeatability of the Pulse Time Index of Norm

Authors Posokhov I, Konradi A, Shlyakhto E, Mamontov O, Orlov A, Rogoza A

Received 30 November 2013

Accepted for publication 17 January 2014

Published 27 February 2014 Volume 2014:7 Pages 29—33


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Igor N Posokhov,1 Aleksandra O Konradi,2 Eugeny V Shlyakhto,2 Oleg V Mamontov,2 Artemy V Orlov,3 Anatoly N Rogoza4

1Hemodynamic Laboratory Ltd, Nizhniy Novgorod, 2Almazov Federal Heart, Blood and Endocrinology Centre, Saint Petersburg, 3Department 65 Competitive System Analysis, National Research Nuclear University, Moscow, 4Cardiology Research Center, Moscow, Russia

Abstract: The pulse wave velocity (PWV) threshold for hypertensive target organ damage is presently set at 10 meters per second. New 24-hour monitors (eg, BPLab® and Vasotens®) provide several PWV measurements over a period of 24–72 hours. A new parameter, ie, the Pulse Time Index of Norm (PTIN), can be calculated from these data. The PTIN is defined as the percentage of a 24-hour period during which the PWV does not exceed 10 meters per second. The aim of the present study was to test the new PTIN for clinical feasibility using day-to-day repeatability analysis. Oscillometrically generated waveform files (n=85), which were previously used for research studies, were reanalyzed using the new 2013 version software of the Vasotens technology program, which enables calculation of PTIN. The intraclass correlation coefficient was 0.98 and Cronbach's alpha was 0.97, indicating that the PTIN has excellent day-to-day repeatability and internal consistency. The present results show adequate repeatability, and PTIN assessment using the Vasotens technology appears to be feasible.

Keywords: pulse wave velocity, ambulatory, 24-hour, monitoring, Pulse Time Index of Norm, arterial stiffness

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]